<?xml version="1.0" encoding="UTF-8"?>
<p>Numerous neurodegenerative disorders are associated with tRFs. ANG mutants show reduced ribonuclease (RNase) activity and were first implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS) (
 <xref rid="B56" ref-type="bibr">Greenway et al., 2006</xref>). Latterly, a subset of the ALS-associated ANG mutants were observed in Parkinsonâ€™s disease (PD) patients (
 <xref rid="B152" ref-type="bibr">van Es et al., 2011</xref>). Recombinant ANG can improve life span and motor function in an ALS [SOD1 (G93A)] mouse model, demonstrating that tRFs may have an important role in motor neuron survival (
 <xref rid="B78" ref-type="bibr">Kieran et al., 2008</xref>) (
 <xref rid="T3" ref-type="table">Table 3</xref>).
</p>
